Bellalgin

General characteristics. Structure:

Active ingredients: 1 tablet contains metamizol of sodium salt 250 mg; benzocaine – 250 mg; extract of a belladonna dense – 15 mg; Natrii hydrocarbonas – 100 mg; excipients: potato starch, talc, stearic acid, emulsion silicone KE 10-12, liquid paraffin. Physical and chemical properties: tablets of a round form, with a flat surface, from clear-brown till ocherous color with light brown impregnations, with slanted edges (facet) and risky.

Pharmacological properties:

Thanks to m - cholinolytically to effect of extract of a belladonna drug reduces a tone and a physical activity of smooth muscles of digestive tract and other bodies, reduces secretion of excretory glands. Analgeziruyushchy effect of drug is caused by effects of metamizole sodium and local anesthetic – benzocaine. Natrii hydrocarbonas neutralizes free hydrochloric acid in a stomach.

Indications to use:

Dispeptic frustration (heartburn; eructation; pains in epigastriums; intestinal gripes) at:
• hyperacid (with a hyperoxemia) gastritis;
• peptic ulcer of a stomach and duodenum;
• cholelithiasis;
• spastic colitis.

Route of administration and doses:

Bellalgin is intended for symptomatic short-term use therefore duration of treatment is selected individually. If symptoms of a disease do not pass within 3 – 5 days, it is necessary to see a doctor for review of tactics of treatment. Drug is used inside on 1 tablet 2 – 3 times a day after food. The highest doses for adults: one-time – 3 tablets, daily – 10 tablets.

Features of use:

Use during pregnancy or feeding by a breast.
Use of drug during pregnancy is justified only when the estimated advantage for mother exceeds potential risk for a fruit.
In case of drug use by the women nursing feeding should be stopped.

Ability to influence speed of response at control of motor transport or other mechanisms.
Use for patients whose activity demands high concentration of attention and speed of psychomotor reactions is not recommended.

Children.
Clinical data on efficiency and safety of use for children are absent, therefore patients should not appoint younger Bellalgin than 14 years.

Appropriate actions at use.

Before an initiation of treatment Bellalgin it is necessary to consult to the doctor.
Because of a possibility of development of an alkalosis (disturbance of acid-base equilibrium in an organism) the long time is not recommended to accept drug.
At patients with atopic bronchial asthma and pollinoses (an allergy to flower pollen) the risk of development of reactions of hypersensitivity is increased.
Apply with care at patients with a serious illness of cardiovascular system.
During administration of drug coloring of urine in red color due to removal of a metabolite of metamizole sodium is possible.
If symptoms of a disease do not begin to disappear or, on the contrary, the state of health will worsen, or there will be undesirable phenomena, it is necessary to suspend administration of drug and to see behind consultation a doctor of rather further use.

Side effects:

In the recommended dose drug usually well is transferred, however the following side reactions are possible:
from the alimentary system: dryness in a mouth, thirst, a lock;
from system of a hemopoiesis: the leukopenia, thrombocytopenia, an agranulocytosis (caused by the metamizole sodium which is a part);
allergic reactions: small tortoiseshell, Quincke's disease;
from a nervous system: dizziness, weakness, headache, frustration of a dream, excitement;
from organs of sight: expansion of pupils is possible (mydriasis);
from cardiovascular system: developing of tachycardia (the speeded-up heartbeat) is possible.
In case of any negative reactions it is necessary to consult to the doctor of rather further use of drug!

Interaction with other medicines:

If you accept any other medicines, surely report about it to the doctor.
The effect of metamizole sodium is strengthened by codeine, blockers _{of H2 receptors} and propranolol.
Co-administration with other non-narcotic analgesics, tricyclic antidepressants, hormonal contraceptives and Allopyrinolum can lead to strengthening of toxic effects. Metamizol, forcing out peroral gipoglikemiziruyushchy drugs, indirect anticoagulants, glucocorticosteroids and indometacin from communication with protein, increases their activity.

Contraindications:

• Hypersensitivity to drug ingredients;
• glaucoma;
• chronic diseases of a liver and kidneys;
• benign hyperplasia of a prostate;
• hemopoiesis oppression, neutropenia;
• pregnancy;
• children's age up to 14 years.

Overdose:

At overdose manifestations of side effects amplify.
At overdose it is necessary to ask for medical care immediately!

Storage conditions:

To store in dry, protected from light, the place, unavailable to children, at a temperature from 15 °C up to 25 ºС.

Period of validity - 3 years.

Issue conditions:

Without recipe

Packaging:

On 10 tablets in planimetric bezjyacheykovy packaging.
On 10 tablets in the blister, on 1 blister in a pack.